Author

Chi‐Ming Che

State Key Laboratory of Synthetic ChemistryORCID 0000-0002-2554-7219Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:benchmark study· 1 Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Alice S.T. WongiD· 1 shared Ayon Ahmed HassaniD· 1 shared Chenhui ZhangiD· 1 shared Chun Nan Lok· 1 shared Katie Sze Wai Fung· 1 shared Li TianiD· 1 shared Lydia W.T. CheungiD· 1 shared Nan LiuiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alice S.T. WongORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioinformaticsbioRxivPreprintSep 22, 2026

Benchmarking Uncertainty and Improving Risk Ranking in Multi-task Bioactivity Prediction

Zijian Wang, Li Tian, Chi‐Ming Che

The paper benchmarks uncertainty estimation and risk ranking in multi-task bioactivity prediction, introducing ICSR to improve reliability of kernel-based predictions.

DOI 10.64898/2026.09.15.751772

statistical modelbenchmark study

𝕏 PostBluesky

Cancer BiologybioRxivPreprintOct 17, 2025

Cancer-specific sialylation of insulin-like growth factor 1 receptor impairs therapeutic antibody binding and efficacy

Ayon Ahmed Hassan, Qiushi Chen, Katie Sze Wai Fung…·Alice S.T. Wong

This paper shows that cancer-specific sialylation of IGF1R reduces ganitumab binding and efficacy, and that desialylation enhances therapeutic response.

DOI 10.1101/2025.10.17.682592

humanproteomics

𝕏 PostBluesky